Abstract
Various animal models are available for studying human multiple sclerosis (MS). Most of them model the initial phase of MS, including the immune-triggered attack of the myelin membrane and/or oligodendrocytes and, occasionally, demonstrate the remission and relapsing phases. However, few mimic the late chronic demyelinating phase. Overexpression of the proteolipid protein gene (Plp) causes a unique demyelinating disorder in mice in which normal-appearing myelin forms early in life and chronic demyelination occurs later. We found that remyelination is severely affected in this late demyelinating phase, but is not caused by deprivation of oligodendrocyte progenitors expressing PDGF receptor alpha (PDGFRα) and Olig2, which are present at an even higher number in the demyelinated white matter of the mutants than in wild-type controls. Furthermore, mature oligodendrocytes containing PLP were observed, but failed to remyelinate. The ability of oligodendrocytes from older transgenic animals to produce a myelin membrane-like structure was not impaired when cultured in vitro, which indicates that the lack of remyelination is not simply caused by changes in the intrinsic properties of the oligodendrocytes. Glial activation also occurred much earlier than active demyelination in mutant mice. Thus, in addition to intrinsic mechanisms, extrinsic mechanisms might also have an important role in defects of remyelination. These features are also observed in patients at a late stage of MS, leading to chronic demyelinating lesions. Thus, this mouse model partly mimics the late stage of MS and can be used to study the cause of inhibition of remyelination.
| Original language | English |
|---|---|
| Pages (from-to) | 81-91 |
| Number of pages | 11 |
| Journal | Neuron Glia Biology |
| Volume | 2 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2006 May |
| Externally published | Yes |
Fingerprint
Keywords
- Glial activation
- Neuropathology
- Oligodendrocyte
- Oligodendrocyte progenitor
- Proteolipid protein
ASJC Scopus subject areas
- Cell Biology
- Cellular and Molecular Neuroscience
Cite this
An animal model for late onset chronic demyelination disease caused by failed terminal differentiation of oligodendrocytes. / Ma, Jianmei; Matsumoto, Michio; Tanaka, Kenji; Takebayashi, Hirohide; Ikenaka, Kazuhiro.
In: Neuron Glia Biology, Vol. 2, No. 2, 05.2006, p. 81-91.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - An animal model for late onset chronic demyelination disease caused by failed terminal differentiation of oligodendrocytes
AU - Ma, Jianmei
AU - Matsumoto, Michio
AU - Tanaka, Kenji
AU - Takebayashi, Hirohide
AU - Ikenaka, Kazuhiro
PY - 2006/5
Y1 - 2006/5
N2 - Various animal models are available for studying human multiple sclerosis (MS). Most of them model the initial phase of MS, including the immune-triggered attack of the myelin membrane and/or oligodendrocytes and, occasionally, demonstrate the remission and relapsing phases. However, few mimic the late chronic demyelinating phase. Overexpression of the proteolipid protein gene (Plp) causes a unique demyelinating disorder in mice in which normal-appearing myelin forms early in life and chronic demyelination occurs later. We found that remyelination is severely affected in this late demyelinating phase, but is not caused by deprivation of oligodendrocyte progenitors expressing PDGF receptor alpha (PDGFRα) and Olig2, which are present at an even higher number in the demyelinated white matter of the mutants than in wild-type controls. Furthermore, mature oligodendrocytes containing PLP were observed, but failed to remyelinate. The ability of oligodendrocytes from older transgenic animals to produce a myelin membrane-like structure was not impaired when cultured in vitro, which indicates that the lack of remyelination is not simply caused by changes in the intrinsic properties of the oligodendrocytes. Glial activation also occurred much earlier than active demyelination in mutant mice. Thus, in addition to intrinsic mechanisms, extrinsic mechanisms might also have an important role in defects of remyelination. These features are also observed in patients at a late stage of MS, leading to chronic demyelinating lesions. Thus, this mouse model partly mimics the late stage of MS and can be used to study the cause of inhibition of remyelination.
AB - Various animal models are available for studying human multiple sclerosis (MS). Most of them model the initial phase of MS, including the immune-triggered attack of the myelin membrane and/or oligodendrocytes and, occasionally, demonstrate the remission and relapsing phases. However, few mimic the late chronic demyelinating phase. Overexpression of the proteolipid protein gene (Plp) causes a unique demyelinating disorder in mice in which normal-appearing myelin forms early in life and chronic demyelination occurs later. We found that remyelination is severely affected in this late demyelinating phase, but is not caused by deprivation of oligodendrocyte progenitors expressing PDGF receptor alpha (PDGFRα) and Olig2, which are present at an even higher number in the demyelinated white matter of the mutants than in wild-type controls. Furthermore, mature oligodendrocytes containing PLP were observed, but failed to remyelinate. The ability of oligodendrocytes from older transgenic animals to produce a myelin membrane-like structure was not impaired when cultured in vitro, which indicates that the lack of remyelination is not simply caused by changes in the intrinsic properties of the oligodendrocytes. Glial activation also occurred much earlier than active demyelination in mutant mice. Thus, in addition to intrinsic mechanisms, extrinsic mechanisms might also have an important role in defects of remyelination. These features are also observed in patients at a late stage of MS, leading to chronic demyelinating lesions. Thus, this mouse model partly mimics the late stage of MS and can be used to study the cause of inhibition of remyelination.
KW - Glial activation
KW - Neuropathology
KW - Oligodendrocyte
KW - Oligodendrocyte progenitor
KW - Proteolipid protein
UR - http://www.scopus.com/inward/record.url?scp=33645500037&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645500037&partnerID=8YFLogxK
U2 - 10.1364/JOSAB.23.000081
DO - 10.1364/JOSAB.23.000081
M3 - Article
C2 - 18634583
AN - SCOPUS:33645500037
VL - 2
SP - 81
EP - 91
JO - Neuron Glia Biology
JF - Neuron Glia Biology
SN - 1740-925X
IS - 2
ER -